Highly potent cyclic disulfide antagonists of somatostatin

Journal of Medicinal Chemistry

Volumn 42, Issue 11, 1999, Pages 1863-1871

  Hocart, Simon J ^a   Jain, Rahul ^a,c   Murphy, William A ^a   Taylor, John E ^b   Coy, David H ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Biomeasure Inc   (United States)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DC 3848; PRL 2858; PRL 2859; PRL 2869; PRL 2872; PRL 2874; PRL 2875; PRL 2876; PRL 2877; PRL 2879; PRL 2882; PRL 2888; PRL 2889; PRL 2891; PRL 2900; PRL 2903; PRL 2904; PRL 2908; PRL 2910; PRL 2915; PRL 2970; PRL 2972; PRL 3020; PRL 3023; PRL 3024; PRL 3052; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONCENTRATION RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; GROWTH HORMONE RELEASE; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; HUMANS; MALE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PITUITARY GLAND, ANTERIOR; RADIOLIGAND ASSAY; RATS; RECEPTORS, SOMATOSTATIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0033519639     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9806289     Document Type: Article

References (49)

1. Brazeau, P.; Vale, W.; Burgus, R.; Ling, N.; Butcher, M.; Rivier, J.; Guillemin, R. Hypothalamic Polypeptide that Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone. Science 1973, 179, 77-79.
2. Mandarino, L.; Stenner, D.; Blanchard, W.; Nissen, S.; Gerich, J.; Ling, N.; Brazeau, P.; Bohlen, P.; Esch, F.; Guillemin, R. Selective Effects of Somatostatin -14, -25, and -28 on in vivo Insulin and Glucagon Secretion. Nature 1981, 291, 76-77.
3. Bloom, S.; Mortimer, C.; Thorner, M.; Besser, G.; Hall, R.; Gomez-Pan, A.; Roy, U.; Russel, R.; Coy, D.; Kastin, A.; Schally, A. Inhibition of Gastrin and Gastric Acid Secretion by Growth Hormone Release-Inhibiting Hormone. Lancet 1974, 2, 1106-1109.
4. Renaud, L.; Martin, J.; Brazeau, P. Depressant Action of TRH, LHRH and SRIF on Activity of Central Neurons. Nature 1975, 255, 233-235.
5. Dodd, J.; Kelly, J. Is Somatostatin an Excitatory Transmitter in the Hippocampus? Nature 1978, 273, 674-677.
6. Chesselet, M. F.; Reisine, T. Somatostatin Regulates Dopamine Release in Rat Striatal Slices and Cat Caudate Nuclei. J. Neurosci. 1983, 3, 232-236.
7. Gothert, M. Somatostatin Selectively Inhibits Noradrenaline Release from Hypothalamic Neurons. Nature 1980, 288, 86-88.
8. Havlicek, V.; Rezek, M.; Freisen, H. Somatostatin and Thyrotropin Releasing Hormone Central Effect on Sleep and Motor Systems. Pharmacol. Biochem. Behav. 1976, 4, 455-459.
9. Schettini, G. Brain Somatostatin: Receptor-Coupled Transducing Mechanisms and role in Cognitive Functions. Pharmacol. Res. 1991, 23, 203-215.
10. Reisine, T.; Bell, G. I. Molecular Properties of Somatostatin Receptors. Neuroscience 1995, 67, 777-790.
11. Reisine, T.; Bell, G. I. Molecular Biology of Somatostatin Receptors. Endocrine Rev. 1995, 16, 427-442.
12. Coy, D. H.; Taylor, J. E. Receptor-Specific Somatostatin Analogues: Correlations with Biological Activity. Metabolism 1996, 34 (Suppl. 1), 21-23.
13. Raynor, K.; Murphy, W. A.; Coy, D. H.; Taylor, J. E.; Moreau, J.-P.; Yasuda, K.; Bell, G. I.; Reisine, T. Cloned Somatostatin Receptors: Identification of Subtype-Selective Peptides and Demonstration of High Affinity Binding of Linear Peptides. Mol. Pharmacol. 1993, 43, 838-844.
14. Rossowski, W. J.; Coy, D. H. Specific Inhibition of Rat Pancreatic Insulin and Glucagon Release by Receptor-Selective Somatostatin Analogues. Biochem. Biophys. Res. Commun. 1994, 205, 341-346.
15. Rossowski, W. J.; Gu, Z. F.; Akarca, U. S.; Jensen, R. T.; Coy, D. H. Characterization of Somatostatin Receptor Subtypes Controlling Rat Gastric Acid and Pancreatic Amylase Release. Peptides 1994, 15, 1421-1424,
16. Murthy, K. S.; Coy, D. H.; Makhlouf, G. M. Somatostatin Receptor-Mediated Signaling in Smooth Muscle - Activation of Phospholipase C-β3 by Gβgamma and Inhibition of Adenyl Cyclase by GαilGαo. J. Biol. Chem. 1996, 271, 23458-23463.
17. O'Carroll, A.-M.; Raynor, K.; Lolait, S. J.; Reisine, T. Characterization of Cloned Human Somatostatin Receptor SSTR5. Mol. Pharmacol. 1994, 46, 291-298.
18. Rossowski, W.; Coy, D. H. Potent Inhibitory effects of a Type Four Receptor Selective Somatostatin Analogue on Rat Insulin Release. Biochem. Biophys. Res. Commun. 1993, 197, 366-371.
19. Fries, J. L.; Murphy, W. A.; Sueiras-Diaz, J.; Coy, D. H. Somatostatin Antagonist Analogue Increases GH, Insulin and Glucagon Release in the Rat. Peptides 1982, 3, 811-814.
20. Spencer, G. S. G.; Hallett, K. G. Somatostatin Antagonist Analogue Stimulates Growth in Rats. Life Sci. 1985, 37, 27-30.
21. Hocart, S. J.; Jain, R.; Murphy, W. A.; Taylor, J. E.; Morgan, B.; Coy, D. H. Potent Antagonists of Somatostatin, Synthesis and Biology. J. Med. Chem. 1998, 41, 1146-1154.
22. Bass, R. T.; Buckwalter, B. L.; Patel, B. P.; Pausch, M. H.; Price, L. A.; Strnad, J.; Hadcock, J. R. Identification and Characterization of Novel Somatostatin Antagonists. Mol. Pharmacol. 1996, 50, 709-715.
23. Bass, R. T.; Buckwalter, B. L.; Patel, B. P.; Pausch, M. H.; Price, L. A.; Strnad, J.; Hadcock, J. R. Identification and Characterization of Novel Somatostatin Antagonists, Erratum. Mol. Pharmacol. 1997, 51, 170.
24. Coy, D. H.; Murphy, W. A.; Rossowski, W. J.; Hocart, S. J.; Jain, R.; Fuselier, J.; Taylor, J. E. Somatostatin Receptor Antagonists based an a mixed Neuromedin B Antagonist/Somatostatin Agonist. In Peptides: Frontiers of Peptide Science, Proceedings of the Fifteenth American Peptide Symposium; Tam, J. P., Kaumaya, P. T. P., Eds.; Kluwer: Dordrecht, The Netherlands, 1999; pp 526-529.
25. Brady, S. F.; Nutt, R. F.; Holly F. W.; Paleveda, W. J.; Strachan, R. G.; Bergstrand, S. J.; Veber, D. F.; Saperstein, R. Synthesis and Biological Activity of Somatostatin Analogues of Reduced Ring Size. In Peptides: Synthesis, Structure, Function, Proceedings of the Seventh American Peptide Symposium; Rich, D. H., Gross, E., Eds.; Pierce Chemical Co.: New York, 1981; pp 653-656.
26. Veber, D. F. Design of a Highly Active Cyclic Hexapeptide Analogue of Somatostatin. In Peptides: Synthesis, Structure, Function. Proceedings of the Seventh American Peptide Symposium; Rich, D. H., Gross, E., Eds.; Pierce Chemical Co.: New York, 1981; pp 685-694.
27. Veber, D. F.; Saperstein, R.; Nutt, R. F.; Freidinger, R. M.; Brady, S. F.; Curley, P.; Perlow, D. S.; Paleveda, W. J.; Colton, C. D.; Zacchei, A. G.; Tocco, D. J.; Hoff, D. R.; Vandlen, R. L.; Gerich, J. E.; Hall, L.; Mandarino, L.; Cordes, E. H.; Anderson, P. S.; Hirschmann, R. A Super Active Cyclic Hexapeptide Analogue of Somatostatin. Life Sci. 1984, 34, 1371-137.
28. Veber, D. F. Design and Discovery in the Development of Peptide Analogues. In Peptides: Chemistry and Biology. Proceedings of the Twelfth American Peptide Symposium; Smith, J. A., Rivier, J. E., Eds.; ESCOM: Leiden, 1992; pp 3-14.
29. Murphy, W. A.; Heiman, M. L.; Lance, V.; Mezo, I.; Coy, D. H. Octapeptide Analogues of Somatostatin Exhibiting Greatly Enhanced in vivo and in vitro Inhibition of Growth Hormone Secretion in the Rat. Biochem. Biophys. Res. Commun. 1985, 132, 922-928.
30. Freidinger, R. M.; Schwenk Perlow, D.; Randall, W. C.; Saperstein, R.; Arison, B. H.; Veber, D. F. Conformational Modifications of Cyclic Hexapeptide Somatostatin Analogues. Int. J. Pept. Protein Res. 1984, 23, 142-150.
31. Ösapay, G.; Prokai, L.; Ho-Seung, K.; Medzihradszky, K F.; Coy, D. H.; Liapakis, G.; Reisine, T.; Melacini, G.; Zhu, Q.; Wang, S. H.-H.; Mattern, R.-H.; Goodman, M. Lanthionine-Somatostatin Analogues: Synthesis, Characterization, Biological Activity, and Enzymatic Stability Studies. J. Med. Chem. 1991, 40, 2241-2251.
32. Chen, L.; Skinner, S. R.; Gordon, T. D.; Taylor, J. E.; Barany, G.; Morgan, B. A. Isolation, Characterization and Synthesis of a Trisulfide Related to the Somatostatin Analogue Lanreotide. In Peptides: Frontiers of Peptide Science, Proceedings of the Fifteenth American Peptide Symposium; Tam, J. P., Kaumaya, P. T. P., Eds.; Kluwer: Dordrecht, The Netherlands, 1999; pp 275-276.
33. Thurieau, C.; Janiak, P.; Krantic, S.; Guyard, C.; Pillon, A.; Kucharczyk, N.; Vilaine, J.-P.; Fauchère, J.-L. A New Somatostatin Analogue with Optimized Ring Size Inhibits Neointimal Formation Induced by Balloon Injury in Rats Without Altering Growth Hormone Release. Eur. J. Med. Chem. 1995, 30, 115-122.
34. Van Binst, G.; Tourwé, D. Backbone Modifications in Somatostatin Analogues: Relation Between Conformation and Activity. Pept. Res. 1992, 5, 8-13.
35. Rossowski, W. J.; Cheng, B.-L.; Jiang, N.-Y.; Coy, D. H. Examination of Somatostatin Involvement in the Inhibitory Action of GIP, GLP-1, Amylin and Adrenomedullin on Gastric Acid Release using a new SRIF Antagonist Analogue. Br. J. Pharmacol. 1998, 125, 1081-1087.
36. 2 which had retention times in the TFA HPLC system of LCys, 30.3; DCys, 30.9; LNal, 36.6; DNal, 37.8 min, respectively.
37. Binding data not shown.
38. Reisine, T.; Bell, G. I. Molecular Properties of Somatostatin Receptors Neuroscience 1995, 67, 777-790.
39. Liapakis, G.; Hoeger, C.; Rivier, J.; Reisine, T. Development of a Selective Agonist at the Somatostatin Receptor Subtype SSTR1. J. Pharmacol. Exp. Ther. 1996, 276, 1089-1094.
40. Hoyer, D.; Bell, G. I.; Berelewitz, M.; Epelbaum, J.; Feniuk, W.; Humphrey, P. P. A.; O'Carroll, A.-M.; Patel, Y. C.; Schonbrunn, A.; Taylor, J. E.; Reisine, T. Classification and Nomenclature of Somatostatin Receptors. Trends Pharmacol. Sci. 1995,16, 86-88.
41. Bruno, J.-F.; Xu, Y.; Song, J.; Berelowitz, M. Molecular Cloning and Functional Expression of a Novel Brain Specific SRIF Receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11151-11155.
42. O'Carroll, A.-M.; Lolait, S. J.; Konig, M.; Mahan, L. C. Molecular Cloning and Expression of a Pituitary SRIF Receptor with Preferential Affinity for SRIF-28. Mol. Pharmacol. 1992, 42, 939-946.
43. IUPAC-IUB Commission of Biochemical Nomenclature (CBN) Symbols for Amino-Acid Derivatives and Peptides, Recommendations 1971. Eur. J. Biochem. 1972, 27, 201-207.
44. Murphy, W. A.; Taylor, J.; Moreau, J.-P.; Coy, D. H. Novel Heptapeptide Somatostatin Analogue Displays Antitumor Activity Independent of Effects on Growth Hormone Secretion. Pept. Res. 1989, 2, 128-132.
45. Yamada, Y.; Post, S. R.; Wang, K.;Tager, H. S.; Bell, G. I.; Seino, S. Cloning and Functional Characterization of a Family of Human and Mouse Somatostatin Receptors Expressed in Brain, Gastrointestinal Tract and Kidney. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 251-255,
46. Yasuda, K.; Rens-Domiano, S.; Breder, C. D.; Law, S. F.; Sapel, C. B.; Reisine, T.; Bell, G. I. Cloning of a Novel Somatostatin Receptor, SSTR-3, Coupled to Adenyl Cyclase. J. Biol. Chem. 1992, 267, 20422-20428.
47. Yamada, Y.; Reisine, T.; Law, S. F.; Ihara, Y.; Kubota, A.; Kagimoto, S.; Seino, M.; Seino, Y.; Bell, G. I.; Seino, S. Somatostatin Receptors, an Expanding Gene Family: Cloning and Functional Characterization of Human SSTR3, a Protein Coupled to Adenylate Cyclase. Mol. Pharmacol. 1992, 42, 2136-2142.
48. Rohrer, L.; Raulf, F.; Bruns, C.; Buettner, R.; Hofstaedter, F.; Schule, R. Cloning and Characterization of a Fourth Human Somatostatin Receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 4196-4200.
49. Taylor, J. E. Personal communication.